Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The old v3.0.1 tag was removed and the Back to Top navigation control was deleted.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to include new studies related to cancer immunotherapy, specifically focusing on lenvatinib and pembrolizumab, while also removing some previously listed location details and related terms.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.